Product correctly added to cart.

discount label
14-3-3 eta antibody
View 3D

Biosynth logo

14-3-3 eta antibody

Ref. 3D-70R-32252

100µg
459.00 €
Estimated delivery in United States, on Tuesday 26 Nov 2024

Product Information

Name:
14-3-3 eta antibody
Description:

6-Fluoro-3-indoxyl-beta-D-galactopyranoside:
Experience the power of 6-Fluoro-3-indoxyl-beta-D-galactopyranoside, the ultimate antituberculosis drug from the rifamycins class. This potent compound is specifically designed to combat tuberculosis infection by targeting active compounds and exhibiting bactericidal activity. Its unique mechanism of action involves binding to DNA-dependent RNA polymerase, effectively preventing transcription and replication. With its high frequency of human activity demonstrated through patch-clamp technique on human erythrocytes, it is a reliable choice for treating tuberculosis. Additionally, this drug undergoes various metabolic transformations, ensuring optimal efficacy. Don't let tuberculosis hold you back - choose 6-Fluoro-3-indoxyl-beta-D-galactopyranoside for a brighter future.

Tilmicosin:
Introducing Tilmicosin, the macrolide antibiotic that is revolutionizing veterinary

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-70R-32252 14-3-3 eta antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".